Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update) [Internet]
- PMID: 20704054
- Bookshelf ID: NBK11681
Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update) [Internet]
Excerpt
The guideline makes recommendations for the treatment and management of schizophrenia. It aims to improve access and engagement with treatment and services for people with schizophrenia; evaluate the role of specific psychological and psychosocial interventions in the treatment of schizophrenia; evaluate the role of specific pharmacological interventions in the treatment of schizophrenia; evaluate the role of specific service level interventions for people with schizophrenia; integrate the above to provide best-practice advice on the care of people with schizophrenia and their family and carers; and promote the implementation of best clinical practice through the development of recommendations tailored to the requirements of the NHS in England and Wales.
Copyright © 2009, National Collaborating Centre for Mental Health.
Sections
- Guideline Development Group members
- Acknowledgements
- 1. Preface
- 2. Schizophrenia
- 3. Methods used to update this guideline
- 4. Experience of care
- 5. Access and engagement
- 6. Pharmacological interventions in the treatment and management of schizophrenia
- 7. Economic model – cost effectiveness of pharmacological interventions for people with schizophrenia
- 8. Psychological therapy and psychosocial interventions in the treatment and management of schizophrenia
- 9. Service-level interventions in the treatment and management of schizophrenia
- 10. Clinical evidence summary tables
- 11. Summary of recommendations
- Appendix 1 Scope for the development of the clinical guideline
- Appendix 2 Declarations of interests by GDG members
- Appendix 3 Special advisors to the Guideline Development Group
- Appendix 4 Stakeholders and experts who submitted comments in response to the consultation draft of the guideline
- Appendix 5 Researchers contacted to request information about unpublished or soon-to-be published studies
- Appendix 6 Analytic framework and clinical questions
- Appendix 7 Clinical review protocol template
- Appendix 8 Search strategies for the identification of clinical studies
- Appendix 9 Quality checklists for clinical studies and reviews
- Appendix 10 Search strategies for the identification of health economics evidence
- Appendix 11 Quality checklist for economic studies
- Appendix 12 Data extraction form for economic studies
- Appendix 13 Winbugs codes used for Mixed Treatment Comparisons in the economic model of pharmacological treatments for relapse prevention
- Appendix 14 Evidence tables for economic studies
- Appendix 15 Study characteristics tables
- Appendix 16 Clinical evidence forest plots
- Appendix 17 Previous guideline methodology
- References
Publication types
LinkOut - more resources
Full Text Sources
